RPG Life Sciences Stock Screener | Share Price & Fundamental Analysis
RPGLIFE
Pharmaceuticals
Share Price NSE
₹1872.60
▼
-18.20 (-0.96%)
Share Price BSE
₹1883.25
▼
-12.35 (-0.65%)
Track RPG Life Sciences share price live with TickJournal's free stock screener.
Analyze RPG Life Sciences share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
RPG Life Sciences Market Cap
₹3,177.48 Cr.
RPGLIFE P/E Ratio (TTM)
15.34
RPG Life Sciences P/B Ratio
187.28
EPS (TTM)
₹110.80
Dividend Yield
1.28%
Debt to Equity
-
RPGLIFE 52 Week High
₹2657.80
RPG Life Sciences 52 Week Low
₹1744.00
Operating Margin
37.00%
Profit Margin
50.65%
RPGLIFE Revenue (TTM)
₹231.00
EBITDA
₹140.00
Net Income
₹117.00
Total Assets
₹658.00
Total Equity
₹531.00
RPG Life Sciences Share Price History - Stock Screener Chart
Screen RPGLIFE historical share price movements with interactive charts. Analyze price trends and patterns.
RPG Life Sciences Company Profile - Fundamental Screener
Screen RPG Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for RPGLIFE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE105J01010
RPG Life Sciences Balance Sheet Screener
Screen RPGLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 658 | 513 | 419 | 345 | 303 | 267 | 251 | 291 | 247 | 205 |
| Current Assets | 465 | 298 | 264 | 207 | 176 | 126 | 97 | 143 | 96 | 87 |
| Fixed Assets | 172 | 114 | 124 | 104 | 113 | 123 | 128 | 131 | 137 | 109 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 7 | 7 | 9 | 9 | 7 | 8 | 13 | 16 | 21 | 5 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 531 | 375 | 308 | 256 | 216 | 177 | 161 | 155 | 147 | 134 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 517 | 362 | 294 | 243 | 203 | 163 | 147 | 142 | 134 | 120 |
RPG Life Sciences Income Statement Screener - Profit & Revenue Analysis
Screen RPG Life Sciences income statement and profit fundamentals.
Analyze RPGLIFE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for RPG Life Sciences share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Dec |
|---|---|---|---|---|---|
| Revenue | 231 | 166 | 197 | 183 | 176 |
| Expenses | 90 | 125 | 143 | 149 | 124 |
| EBITDA | 140 | 41 | 55 | 35 | 53 |
| Operating Profit % | 37.00% | 26.00% | 21.00% | 17.00% | 28.00% |
| Depreciation | 5 | 5 | 5 | 5 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 135 | 35 | 50 | 29 | 47 |
| Tax | 18 | 9 | 13 | 7 | 12 |
| Net Profit | 117 | 26 | 37 | 22 | 35 |
| EPS | 70.96 | 15.90 | 22.28 | 13.38 | 21.12 |
RPG Life Sciences Cash Flow Screener - Liquidity Fundamentals
Screen RPGLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 78 | 94 | 91 | 65 | 58 | 50 | 46 | 15 | 7 | 33 |
| Investing Activities | -42 | -79 | -106 | -35 | -8 | -11 | -19 | -16 | -30 | -15 |
| Financing Activities | -27 | -20 | -17 | -14 | -11 | -39 | -27 | 0 | 23 | -18 |
| Net Cash Flow | 9 | -5 | -32 | 17 | 40 | 0 | 0 | -1 | 1 | 0 |
RPG Life Sciences Shareholding Pattern Screener
See RPG Life Sciences shareholding pattern with promoter, FII, and DII holdings.
Check RPG Life Sciences promoter holding and ownership changes for RPGLIFE on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.95% | 72.95% | 72.95% | 72.95% | 72.95% | 72.81% | 72.81% | 72.81% |
| FII Holding | 1.00% | 1.11% | 1.35% | 1.45% | 1.30% | 1.35% | 1.14% | 0.89% |
| DII Holding | 7.04% | 6.70% | 6.48% | 6.14% | 6.06% | 5.45% | 4.63% | 4.19% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.17% | 15.37% | 15.46% | 15.33% | 15.58% | 15.92% | 16.79% | 17.41% |
| Other Holding | 3.83% | 3.88% | 3.76% | 4.12% | 4.11% | 4.47% | 4.62% | 4.70% |
| Shareholder Count | 25,905 | 26,657 | 25,832 | 24,867 | 24,891 | 23,481 | 22,232 | 22,137 |
RPG Life Sciences Share Dividend Screener - Share Yield Analysis
Check RPG Life Sciences dividend history with payout and yield data.
View RPG Life Sciences dividend details including ex-dates and amounts for RPGLIFE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹24.00 | 1.29% |
| 2024-March | ₹16.00 | 0.70% |
| 2023-March | ₹12.00 | 0.79% |
| 2022-March | ₹9.60 | 1.40% |
| 2021-March | ₹7.20 | 1.28% |
| 2020-March | ₹4.00 | 1.03% |
| 2019-March | ₹2.40 | 1.41% |
| 2018-March | ₹2.40 | 0.97% |
| 2017-March | ₹2.80 | 0.73% |
RPG Life Sciences Stock Index Membership
See which indices include RPG Life Sciences stock.
Check RPGLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
RPG Life Sciences Market Events Screener - Corporate Actions
Get RPG Life Sciences corporate actions including splits, bonuses, and buybacks.
Check RPG Life Sciences stock events that may affect RPGLIFE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-27 | 2026-01-27 | Quarterly Result Announcement | NA | -6.97% |
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 3.21% |
| 2025-07-25 | 2025-07-25 | Quarterly Result Announcement | NA | -1.32% |
| 2025-07-16 | 2025-07-16 | Annual General Meeting | NA | 9.20% |
| 2025-06-27 | 2025-06-27 | Dividend | ₹ 4.00 /share | 8.01% |
| 2025-06-27 | 2025-06-27 | Dividend | ₹ 20.00 /share | 8.01% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 2.14% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 4.82% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 9.41% |
| 2024-07-16 | 2024-07-16 | Annual General Meeting | NA | 6.83% |
| 2024-06-28 | 2024-06-28 | Dividend | ₹ 16.00 /share | 2.52% |
| 2023-07-21 | 2023-07-21 | Dividend | ₹ 12.00 /share | 21.46% |
| 2022-07-14 | 2022-07-15 | Dividend | ₹ 9.60 /share | -3.53% |
| 2021-08-13 | 2021-08-17 | Dividend | ₹ 7.20 /share | 5.31% |
RPG Life Sciences Competitors Screener - Peer Comparison
Screen RPGLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
RPG Life Sciences Company Announcements - News Screener
Screen RPGLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-30 | Closure of Trading Window | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-30 | General Updates | - |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-27 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-27 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-27 | Financial Result Quarter Ended On December 31 2025 | - |
| 2026-01-27 | Board Meeting Outcome for Outcome Of The Board Meeting Held On January 27 2026. | - |
| 2026-01-20 | Board Meeting Intimation for Intimation Of Board Meeting | - |
| 2026-01-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-12-29 | Disclosure Under Regulation 30 Of SEBI LODR 2015 For Details Of Order Received From GST Authority Maharashtra | - |
| 2025-12-24 | Incorporation Of A Wholly Owned Subsidiary. | - |
| 2025-12-24 | Closure of Trading Window | - |
| 2025-12-15 | Disclosure Under Regulation 30(5) | - |
| 2025-12-15 | Intimation With Respect To Proposed Incorporation Of A Wholly Owned Subsidiary Is Enclosed Herewith | - |
| 2025-12-15 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2025-12-15 | Outcome Of The Board Meeting Held On December 15 2025 | - |
| 2025-11-28 | Disclosure Under Regulation 30 Of SEBI LODR 2015 For Details Of Order Received From GST Authority Gujarat. | - |